Lion Tracks EEG Pilot: Understand Cognitive Responses to CrossFit in Mother-Child Dyads
ConditionCognition
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age3+
SponsorPenn State University
About this trial
The purpose of this study is to examine how participating in exercise together versus separately influences brain function, cognitive performance, mood, and parent-child connection in mother-child dyads. Mothers and their children will complete two fitness class visits at a participating community fitness facility/CrossFit affiliate. During one visit, mothers and children will exercise in separate age-appropriate classes, and during the other visit they will exercise together in a shared class. Before and after each exercise session, participants will complete brief assessments of cognition, mood, and brain activity using a portable electroencephalography (EEG) device. Findings from this pilot study will help determine the feasibility of conducting community-based neuroscience research and may inform future family-centered physical activity programs designed to support brain, emotional, and social health.
Eligibility criteria
Qualifiers
Adult participant is a mother or female primary caregiver aged 18 years or older.
Child participant is at least 3 years of age.
Mother and child are willing to participate together as a dyad.
Mother and child are able to understand and speak English.
Disqualifiers
Pregnancy at the time of participation.
Any cardiovascular, metabolic, respiratory, neurological, musculoskeletal, or other medical condition that would make exercise unsafe.
Current injury or physical limitation preventing participation in exercise.
History of seizure disorder or other condition that may interfere with EEG assessment.
Trial design
Treatments tested in this trial
- Family-Based Functional Fitness Exercise
- Independent Functional Fitness Exercise
Treatment groups
20 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov